GlassScriptPhysician profile
Alison M Diesel
NPI 1871987818
$1,052.65
in general payments reported to CMS, 2019-2025
19 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $151 · 2023: $200 · 2024: $462 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $757 · Education: $36.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $757.22 |
| Education | $36.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $164.90 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Esperion Therapeutics, INC. | $106.81 | 2021-2025 | Nexletol |
| Exact Sciences Corporation | $91.93 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $88.10 | 2023-2025 | Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $71.99 | 2023-2024 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $71.26 | 2024-2025 | Otezla, Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $60.96 | 2024-2025 | |
| Pfizer INC. | $55.30 | 2022-2024 | |
| Medtronic, INC. | $53.54 | 2021-2023 | Interstim |
| Amarin Pharma, INC. | $52.53 | 2021-2022 | |
| Astellas Pharma US INC | $35.11 | 2023-2024 | Veozah |
| E.R. Squibb & Sons, L.L.C. | $35.04 | 2021-2024 | Eliquis |
| Kowa Pharmaceuticals America, INC. | $31.22 | 2021-2022 | |
| Nevro Corp. | $27.92 | 2024 | Senza |
| Boston Scientific Corporation | $27.91 | 2024 | Watchman Access System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $21.33 | 2022 | |
| Novo Nordisk INC | $20.85 | 2024 | Ozempic, Rybelsus |
| Phathom Pharmaceuticals, INC. | $19.23 | 2025 | Voquezna |
| Eisai INC. | $16.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Diesel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.